The	0	3	O
semaphorin	4	14	B-Gene_or_gene_product
7A	15	17	I-Gene_or_gene_product
receptor	18	26	O
Plexin	27	33	B-Gene_or_gene_product
C1	34	36	I-Gene_or_gene_product
is	37	39	O
lost	40	44	O
during	45	51	O
melanoma	52	60	B-Pathological_formation
metastasis	61	71	O
.	71	72	O

The	74	77	O
transformation	78	92	O
of	93	95	O
normal	96	102	O
melanocytes	103	114	B-Cell
,	114	115	O
or	116	118	O
melanocyte	119	129	B-Cell
stem	130	134	I-Cell
cells	135	140	I-Cell
,	140	141	O
to	142	144	O
melanoma	145	153	B-Pathological_formation
,	153	154	O
is	155	157	O
a	158	159	O
complex	160	167	O
process	168	175	O
involving	176	185	O
multiple	186	194	O
mechanisms	195	205	O
.	205	206	O

Loss	207	211	O
of	212	214	O
tumor	215	220	B-Pathological_formation
suppressor	221	231	O
proteins	232	240	O
,	240	241	O
which	242	247	O
function	248	256	O
as	257	259	O
brakes	260	266	O
on	267	269	O
cell	270	274	B-Cell
growth	275	281	O
,	281	282	O
migration	283	292	O
,	292	293	O
or	294	296	O
cell	297	301	B-Cell
survival	302	310	O
,	310	311	O
was	312	315	O
recognized	316	326	O
early	327	332	O
on	333	335	O
as	336	338	O
an	339	341	O
important	342	351	O
mechanism	352	361	O
for	362	365	O
initiation	366	376	O
and	377	380	O
progression	381	392	O
of	393	395	O
melanoma	396	404	B-Pathological_formation
.	404	405	O

Semaphorins	406	417	B-Gene_or_gene_product
and	418	421	O
their	422	427	O
cognate	428	435	O
receptors	436	445	O
,	445	446	O
Plexins	447	454	B-Gene_or_gene_product
and	455	458	O
neuropilins	459	470	B-Gene_or_gene_product
,	470	471	O
are	472	475	O
involved	476	484	O
in	485	487	O
neuronal	488	496	O
pathfinding	497	508	O
,	508	509	O
immune	510	516	O
function	517	525	O
,	525	526	O
and	527	530	O
tumor	531	536	B-Pathological_formation
progression	537	548	O
through	549	556	O
effects	557	564	O
on	565	567	O
blood	568	573	B-Multi-tissue_structure
vessel	574	580	I-Multi-tissue_structure
growth	581	587	O
and	588	591	O
cell	592	596	B-Cell
migration	597	606	O
.	606	607	O

Semaphorin	608	618	B-Gene_or_gene_product
7A	619	621	I-Gene_or_gene_product
(	622	623	O
Sema7A	623	629	B-Gene_or_gene_product
)	629	630	O
is	631	633	O
a	634	635	O
membrane	636	644	B-Cellular_component
-	644	645	O
linked	645	651	O
semaphorin	652	662	B-Gene_or_gene_product
that	663	667	O
is	668	670	O
expressed	671	680	O
by	681	683	O
human	684	689	B-Organism
keratinocytes	690	703	B-Cell
,	703	704	O
and	705	708	O
we	709	711	O
have	712	716	O
shown	717	722	O
that	723	727	O
Sema7A	728	734	B-Gene_or_gene_product
binds	735	740	O
to	741	743	O
human	744	749	B-Organism
melanocytes	750	761	B-Cell
through	762	769	O
beta1	770	775	B-Gene_or_gene_product
-	775	776	I-Gene_or_gene_product
integrins	776	785	I-Gene_or_gene_product
and	786	789	O
the	790	793	O
Plexin	794	800	B-Gene_or_gene_product
C1	801	803	I-Gene_or_gene_product
receptor	804	812	O
.	812	813	O

Functional	814	824	O
studies	825	832	O
showed	833	839	O
that	840	844	O
Sema7A	845	851	B-Gene_or_gene_product
stimulates	852	862	O
cytoskeletal	863	875	B-Cellular_component
reorganization	876	890	O
in	891	893	O
human	894	899	B-Organism
melanocytes	900	911	B-Cell
,	911	912	O
resulting	913	922	O
in	923	925	O
adhesion	926	934	O
and	935	938	O
dendrite	939	947	O
formation	948	957	O
.	957	958	O

Downstream	959	969	O
targets	970	977	O
of	978	980	O
Plexin	981	987	B-Gene_or_gene_product
C1	988	990	I-Gene_or_gene_product
signaling	991	1000	O
in	1001	1003	O
human	1004	1009	B-Organism
melanocytes	1010	1021	B-Cell
include	1022	1029	O
cofilin	1030	1037	B-Gene_or_gene_product
and	1038	1041	O
LIM	1042	1045	B-Gene_or_gene_product
kinase	1046	1052	I-Gene_or_gene_product
II	1053	1055	I-Gene_or_gene_product
,	1055	1056	O
both	1057	1061	O
of	1062	1064	O
which	1065	1070	O
are	1071	1074	O
critical	1075	1083	O
mediators	1084	1093	O
of	1094	1096	O
cell	1097	1101	B-Cell
adhesion	1102	1110	O
and	1111	1114	O
migration	1115	1124	O
.	1124	1125	O

In	1126	1128	O
this	1129	1133	O
report	1134	1140	O
,	1140	1141	O
we	1142	1144	O
analyzed	1145	1153	O
the	1154	1157	O
expression	1158	1168	O
of	1169	1171	O
Plexin	1172	1178	B-Gene_or_gene_product
C1	1179	1181	I-Gene_or_gene_product
using	1182	1187	O
immunohistochemistry	1188	1208	O
on	1209	1211	O
sections	1212	1220	O
of	1221	1223	O
primary	1224	1231	O
and	1232	1235	O
matched	1236	1243	O
metastatic	1244	1254	O
lesions	1255	1262	B-Pathological_formation
from	1263	1267	O
19	1268	1270	O
subjects	1271	1279	O
and	1280	1283	O
in	1284	1286	O
a	1287	1288	O
large	1289	1294	O
melanoma	1295	1303	B-Pathological_formation
tumor	1304	1309	I-Pathological_formation
microarray	1310	1320	O
.	1320	1321	O

Our	1322	1325	O
data	1326	1330	O
show	1331	1335	O
a	1336	1337	O
significant	1338	1349	O
loss	1350	1354	O
of	1355	1357	O
Plexin	1358	1364	B-Gene_or_gene_product
C1	1365	1367	I-Gene_or_gene_product
in	1368	1370	O
metastatic	1371	1381	B-Pathological_formation
melanoma	1382	1390	I-Pathological_formation
compared	1391	1399	O
with	1400	1404	O
primary	1405	1412	B-Pathological_formation
melanoma	1413	1421	I-Pathological_formation
,	1421	1422	O
suggesting	1423	1433	O
the	1434	1437	O
possibility	1438	1449	O
that	1450	1454	O
the	1455	1458	O
Plexin	1459	1465	B-Gene_or_gene_product
C1	1466	1468	I-Gene_or_gene_product
receptor	1469	1477	O
is	1478	1480	O
a	1481	1482	O
tumor	1483	1488	B-Pathological_formation
suppressor	1489	1499	O
protein	1500	1507	O
for	1508	1511	O
melanoma	1512	1520	B-Pathological_formation
.	1520	1521	O

